These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26049780)

  • 21. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
    Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole blood thromboelastometry profiles in women with preeclampsia.
    Spiezia L; Bogana G; Campello E; Maggiolo S; Pelizzaro E; Carbonare CD; Gervasi MT; Simioni P
    Clin Chem Lab Med; 2015 Oct; 53(11):1793-8. PubMed ID: 25803079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference Intervals of Thromboelastometric Evaluation of Coagulation in Pediatric Patients with Congenital Heart Diseases: A Retrospective Investigation.
    Kim JY; Shin YR; Kil HK; Park MR; Lee JW
    Med Sci Monit; 2016 Oct; 22():3576-3587. PubMed ID: 27711024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM).
    Theusinger OM; Baulig W; Asmis LM; Seifert B; Spahn DR
    Thromb Haemost; 2010 Aug; 104(2):385-91. PubMed ID: 20431856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
    Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.
    Moore HB; Moore EE; Chapman MP; Gonzalez E; Slaughter AL; Morton AP; D'Alessandro A; Hansen KC; Sauaia A; Banerjee A; Silliman CC
    J Thromb Haemost; 2015 Oct; 13(10):1878-87. PubMed ID: 26256459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlations between ROTEM fibrinolytic activity and t-PA, PAI-1 levels in patients with newly diagnosed multiple myeloma].
    Misiewicz M; Robak M; Chojnowski K; Treliński J
    Pol Merkur Lekarski; 2014 May; 36(215):316-9. PubMed ID: 24964508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents.
    Larsen OH; Fenger-Eriksen C; Christiansen K; Ingerslev J; Sørensen B
    Anesthesiology; 2011 Aug; 115(2):294-302. PubMed ID: 21691196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated thrombelastogram in neonates and infants with complex congenital heart disease in comparison with healthy children.
    Haizinger B; Gombotz H; Rehak P; Geiselseder G; Mair R
    Br J Anaesth; 2006 Oct; 97(4):545-52. PubMed ID: 16873390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Hyperbaric and Decompression Stress on Blood Coagulation and Fibrinolysis: Comparison of Thromboelastography and Thromboelastometry.
    Peng HT; Cameron BA; Rhind SG
    Clin Appl Thromb Hemost; 2016 May; 22(4):327-39. PubMed ID: 25616490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.
    Moore HB; Moore EE; Lawson PJ; Gonzalez E; Fragoso M; Morton AP; Gamboni F; Chapman MP; Sauaia A; Banerjee A; Silliman CC
    Surgery; 2015 Aug; 158(2):386-92. PubMed ID: 25979440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of early thromboelastometric variables from extrinsically activated assays with and without aprotinin for rapid detection of fibrinolysis.
    Dirkmann D; Görlinger K; Peters J
    Anesth Analg; 2014 Sep; 119(3):533-542. PubMed ID: 24977914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans.
    Spiel AO; Mayr FB; Firbas C; Quehenberger P; Jilma B
    J Thromb Haemost; 2006 Feb; 4(2):411-6. PubMed ID: 16420574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysis Timer: a new sensitive tool to diagnose hyperfibrinolysis in liver transplantation.
    Roullet S; Labrouche S; Mouton C; Quinart A; Nouette-Gaulain K; Laurent C; Freyburger G
    J Clin Pathol; 2019 Jan; 72(1):58-65. PubMed ID: 30282673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry.
    Solomon C; Sørensen B; Hochleitner G; Kashuk J; Ranucci M; Schöchl H
    Anesth Analg; 2012 Apr; 114(4):721-30. PubMed ID: 22314689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous fibrinolytic potential in tissue-plasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis.
    Spodsberg EH; Wiinberg B; Jessen LR; Marschner CB; Kristensen AT
    Vet Clin Pathol; 2013 Sep; 42(3):281-90. PubMed ID: 23944273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.